🇺🇸 FDA
Patent

US 8044057

Methods for suppressing an immune response or treating a proliferative disorder

granted A61KA61K31/282A61K31/4745

Quick answer

US patent 8044057 (Methods for suppressing an immune response or treating a proliferative disorder) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/282, A61K31/4745, A61K31/496, A61K31/7034